Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124829323 | 12482932 | 3 | F | 20150610 | 20160629 | 20160620 | 20160701 | EXP | US-SEATTLE GENETICS-2016SGN00966 | SEATTLE GENETICS | 0.00 | Y | 0.00000 | 20160701 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124829323 | 12482932 | 1 | PS | brentuximab vedotin | BRENTUXIMAB VEDOTIN | 1 | Intravenous (not otherwise specified) | 55 MG, QWEEK | 110 | MG | FKL007 | 125388 | 55 | MG | INJECTION | /wk | |||
| 124829323 | 12482932 | 2 | SS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 548 MG, QWEEK | 1370 | MG | 0 | 548 | MG | /wk | |||||
| 124829323 | 12482932 | 3 | C | FLUCONAZOLE ACCORD | 2 | 0 | |||||||||||||
| 124829323 | 12482932 | 4 | C | TACROLIMUS. | TACROLIMUS | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 5 | C | ACYCLOVIR /00587301/ | ACYCLOVIR | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 6 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 9 | C | CALCIUM ACETATE. | CALCIUM ACETATE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 10 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 11 | C | SODIUM CITRATE AND CITRIC ACID | CITRIC ACID MONOHYDRATESODIUM CITRATE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 12 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 13 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 14 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 15 | C | GENERLAC | LACTULOSE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 16 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 17 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 18 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 19 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 20 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 21 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | 0 | ||||||||||||
| 124829323 | 12482932 | 22 | C | SENOKOT | SENNOSIDES | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124829323 | 12482932 | 1 | Post transplant lymphoproliferative disorder |
| 124829323 | 12482932 | 2 | Post transplant lymphoproliferative disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124829323 | 12482932 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124829323 | 12482932 | Acute kidney injury | |
| 124829323 | 12482932 | Chills | |
| 124829323 | 12482932 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124829323 | 12482932 | 1 | 20150527 | 20150603 | 0 | |
| 124829323 | 12482932 | 2 | 20150527 | 20150613 | 0 |